0001209191-19-032277.txt : 20190523 0001209191-19-032277.hdr.sgml : 20190523 20190523160422 ACCESSION NUMBER: 0001209191-19-032277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190521 FILED AS OF DATE: 20190523 DATE AS OF CHANGE: 20190523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Thomas Patrick CENTRAL INDEX KEY: 0001410514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38219 FILM NUMBER: 19850062 MAIL ADDRESS: STREET 1: 60 WESTVIEW STREET CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001654151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200299725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-209-6400 MAIL ADDRESS: STREET 1: 500 TOTTEN POND ROAD CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC DATE OF NAME CHANGE: 20150928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-21 0 0001654151 Deciphera Pharmaceuticals, Inc. DCPH 0001410514 Kelly Thomas Patrick C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD WALTHAM MA 02451 0 1 0 0 Chief Financial Officer Common Stock 2019-05-21 4 M 0 1373 1.89 A 1373 D Common Stock 2019-05-21 4 S 0 1373 25.0683 D 0 D Common Stock 2019-05-22 4 M 0 100 1.89 A 100 D Common Stock 2019-05-22 4 S 0 100 25.00 D 0 D Stock Option (Right to Buy) 1.89 2019-05-21 4 M 0 1373 0.00 D 2025-12-17 Common Stock 1373 151635 D Stock Option (Right to Buy) 1.89 2019-05-22 4 M 0 100 0.00 D 2025-12-17 Common Stock 100 151535 D The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal installments over a 4-year period following the vesting commencement date of 2/23/2015, subject to continued service through such dates. /s/ Thomas P. Kelly 2019-05-23